SR ONE CAPITAL MANAGEMENT, LP

CIK 0001910264 · REDWOOD CITY, CA · Quarter end: 2026-06-30 · Filed on: 2026-08-12 · Open the SEC source

SR ONE CAPITAL MANAGEMENT, LP reported 15 positions worth $1.04B as of June 30, 2026 (13F filed August 12, 2026). Largest holding: MANE (28.4%).

Portfolio Value (AUM)Total value of the fund's US stock portfolio reported to the SEC.
$1.04B
2026 Q2
Positions
15
Top-10 ConcentrationHow much of the portfolio sits in the 10 largest holdings. High = concentrated bets.
95.1%
Est. Net Flow (Q)
2026 Q2
10 / 15 positions shown
#SymbolCompanyTypeValue% Port.Shares1YYTD
1MANEVeradermics, Inc.SH$295.3M28.42%2,401,868
2ZBIOZenas BioPharma, IncSH$127.9M12.31%5,037,854
3CRSPCRISPR Therapeutics AGSH$111.2M10.70%2,038,763
4AVLNAvalyn Pharma, IncSH$108.9M10.48%3,308,649
5DSGNDesign Therapeutics, Inc.SH$94.4M9.09%6,526,476
6ODTXOdyssey Therapeutics, Inc.SH$71.0M6.83%3,794,883
7ALMSAlumis Inc.SH$55.2M5.31%1,959,896
8ORICORIC Pharmaceuticals, Inc.SH$50.0M4.81%4,615,384
9MLYSMineralys Therapeutics Inc.SH$42.2M4.06%1,563,966
10SPRYARS Pharmaceuticals, Inc.SH$32.1M3.09%4,012,903

The free plan shows the top 10 positions. The remaining 5 positions, the full portfolio and quarter changes unlock with Pro.

Pro Feature

This section is exclusive to Fundocap Pro. Full holdings tables, consensus trades, ownership analysis, backtests and exports unlock with Pro.

Upgrade to Pro

Read the 2026-Q2 quarterly report · 13F Filing Calendar

Frequently Asked Questions

What stocks does SR ONE CAPITAL MANAGEMENT, LP hold as of Q2 2026?

SR ONE CAPITAL MANAGEMENT, LP reported 15 positions worth $1.04B in its Q2 2026 13F filing. Largest positions: MANE (28.4%), ZBIO (12.3%), CRSP (10.7%), AVLN (10.5%) and DSGN (9.1%).

What did SR ONE CAPITAL MANAGEMENT, LP buy in Q2 2026?

No previous quarter is available yet; the comparison appears with the next filing.

What did SR ONE CAPITAL MANAGEMENT, LP sell in Q2 2026?

No previous quarter is available yet.

13F data shows quarter-end positions, is delayed by up to 45 days and covers only long positions in US-listed securities; short positions, most derivatives and non-US assets are not reported.